ASCO Genitourinary Cancers Symposium
ASCO GU 2022: Tumor Mutational Burden as a Predictive Biomarker for Immune CPI vs. Chemo Benefit in 1L mUC
By
ASCO Genitourinary Cancers Symposium
FEATURING
Shilpa Gupta
By
ASCO Genitourinary Cancers Symposium
FEATURING
Shilpa Gupta
Login to view comments.
Click here to Login